- Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C, (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7: 32. https://doi.org/10.1186/1750-1172-7-32 [CrossRef] [PubMed] [Google Scholar]
- Maillot F, Blasco H, Lioger B, Bigot A, Douillard C, (2016) Diagnostic et traitement des déficits du cycle de l’urée à l’âge adulte. Rev Med Interne 37: 680–684. https://doi.org/10.1016/j.revmed.2016.02.011 [CrossRef] [PubMed] [Google Scholar]
- Summar ML, Dobbelaere D, Brusilow S, Lee B, (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 97: 1420–1425. https://doi.org/10.1111/j.1651-2227.2008.00952.x [CrossRef] [PubMed] [Google Scholar]
- Kouatchet A, Lebas E, (2007) Encéphalopathie hyperammoniémique par déficit en enzyme du cycle de l’urée. Reanimation 16: 302–309. https://doi.org/10.1016/j.reaurg.2007.05.008 [CrossRef] [Google Scholar]
- Nagamani SCS, Erez A, Lee B, (1993) Argininosuccinate lyase deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al (eds) GeneReviews®. University of Washington, Seattle, Seattle (WA) [Google Scholar]
- Edlow JA, Rabinstein A, Traub SJ, Wijdicks EFM, (2014) Diagnosis of reversible causes of coma. Lancet 384: 2064–2076. https://doi.org/10.1016/S0140-6736(13)62184-4 [CrossRef] [PubMed] [Google Scholar]
- Walker V, (2012) Severe hyperammonaemia in adults not explained by liver disease. Ann Clin Biochem 49: 214–228. https://doi.org/10.1258/acb.2011.011206 [Google Scholar]
- Jeffers LJ, Dubow RA, Zieve L, Reddy KR, Livingstone AS, Neimark S, Viamonte M, Schiff ER, (1988) Hepatic encephalopathy and orotic aciduria associated with hepatocellular carcinoma in a noncirrhotic liver. Hepatol 8: 78–81. [CrossRef] [Google Scholar]
- Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A, (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356: 2282–2292. https://doi.org/10.1056/NEJMoa066596 [CrossRef] [PubMed] [Google Scholar]
Free Access
| Issue |
Méd. Intensive Réa.
Volume 27, Number 6, Novembre 2018
Néphrologie et métabolisme
|
|
|---|---|---|
| Page(s) | 558 - 562 | |
| Section | Cas clinique commenté / Commented case report | |
| DOI | https://doi.org/10.3166/rea-2018-0073 | |
| Published online | 13 December 2018 | |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.